Fuse Medical Past Earnings Performance
Past criteria checks 2/6
There is insufficient data on Fuse Medical's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -5.8% |
| Return on equity | n/a |
| Net Margin | 21.6% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Fuse Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 18 | 4 | 12 | 0 |
| 31 Mar 23 | 18 | 3 | 12 | 0 |
| 31 Dec 22 | 19 | 3 | 12 | 0 |
| 30 Sep 22 | 20 | -1 | 13 | 0 |
| 30 Jun 22 | 20 | -2 | 13 | 0 |
| 31 Mar 22 | 21 | -2 | 14 | 0 |
| 31 Dec 21 | 20 | -2 | 14 | 0 |
| 30 Sep 21 | 21 | -1 | 14 | 0 |
| 30 Jun 21 | 23 | 0 | 14 | 0 |
| 31 Mar 21 | 21 | -1 | 13 | 0 |
| 31 Dec 20 | 21 | -1 | 14 | 0 |
| 30 Sep 20 | 22 | 0 | 14 | 0 |
| 30 Jun 20 | 22 | -4 | 15 | 0 |
| 31 Mar 20 | 23 | -4 | 15 | 0 |
| 31 Dec 19 | 23 | -3 | 14 | 0 |
| 30 Sep 19 | 23 | 1 | 14 | 0 |
| 30 Jun 19 | 24 | 6 | 14 | 0 |
| 31 Mar 19 | 25 | 4 | 14 | 0 |
| 31 Dec 18 | 26 | 4 | 15 | 0 |
| 30 Sep 18 | 26 | -2 | 15 | 0 |
| 30 Jun 18 | 25 | -2 | 13 | 0 |
| 31 Mar 18 | 27 | 0 | 12 | 0 |
| 31 Dec 17 | 26 | 1 | 11 | 0 |
| 31 Dec 16 | 26 | 3 | 11 | 0 |
Quality Earnings: FZMD has a large one-off gain of $4.1M impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: FZMD became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FZMD has become profitable over the past 5 years.
Accelerating Growth: FZMD has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: FZMD has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: FZMD's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.